SCHEMBL30888293

SCHEMBL30888293

Cc1cc2nc(N)nn2cc1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PIK3CG P48736 10/20 0.38
PIK3CD O00329 6/20 0.38
PIK3CA P42336 3/20 0.38
PIK3CB P42338 2/20 0.38
TERT O14746 1/20 0.35
NUDT1 P36639 2/20 0.34
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
APP P05067 1/20 0.33
UHRF1 Q96T88 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16439310 0.85 PDE10A (0.41) KDM4EALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL20299388 0.85 TERT (0.35) KDM4EALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL31489439 0.81 KDM4E (0.41) KDM4EALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL29360543 0.79 MEN1 (0.35) KDM4EALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL30888275 0.78 HTT (0.36) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL30888278 0.78 HTT (0.36) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL30888295 0.75 GAA (0.41) KDM4EALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL25675286 0.71 MTOR (0.40) PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL29134638 0.71 APP (0.40) KDM4EALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL10044580 0.71 PIK3CG (0.44) KDM4EALDH1A1HPGDHSD17B10PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117940437-A DNA-PK selective inhibitor and preparation method and application thereof 首药控股(北京)股份有限公司 2024-04-26 CN disclosed